Q4 2025 International Flavors & Fragrances Inc Earnings Call Transcript
Key Points
- IFF achieved solid sales growth in 2025, with a 4% average sales growth over the last two years.
- The Taste segment grew sales by 4% and EBITDA by 10%, showcasing strong performance.
- Health & Biosciences segment saw a 5% sales increase with a 20% rise in EBITDA, driven by volume growth and productivity gains.
- IFF's net debt to credit adjusted EBITDA improved to 2.6 times, reflecting a more disciplined capital allocation strategy.
- The company is actively pursuing strategic divestitures to focus on high-value innovation-driven businesses, including the sale of its Food Ingredients business.
- Food Ingredients sales declined by 4% due to softness in certain areas and strategic exits from low-margin businesses.
- Fragrance Ingredients faced double-digit declines in commodity ingredient sales, impacting overall segment performance.
- The company experienced higher working capital outflows, partly due to increased inventory levels.
- IFF's free cash flow for 2025 was lower than expected, impacted by higher Reg G-related charges and working capital issues.
- Macroeconomic uncertainty and geopolitical volatility are expected to persist, potentially impacting 2026 performance.
At this time, I would like to welcome everyone to the IFF Fourth Quarter and Full Year 2025 Earnings Conference Call. (Operator Instructions)
I would now like to introduce Michael Bender, Head of Investor Relations. You may begin.
Thank you. Good morning, good afternoon and good evening, everyone. Welcome to IFF's Fourth Quarter and Full Year 2025 Conference Call. Yesterday afternoon, we issued a press release announcing our financial results. A copy of the release can be found on our IR website at ir.iff.com. Please note that this call is being recorded live and will be available for replay.
During the call, we'll be making forward-looking statements about the company's performance and business outlook. These statements are based on how we see things today and contain elements of uncertainty. For additional information concerning the factors that can cause actual results to differ materially, please refer to our cautionary statement and risk factors
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

